Topical application of laminin-332 to diabetic mouse wounds

Journal of Dermatological Science

Volumn 48, Issue 3, 2007, Pages 177-188

  Sullivan, Stephen R ^a   Underwood, Robert A ^a   Sigle, Randall O ^b   Fukano, Yuko ^a   Muffley, Lara A ^a   Usui, Marcia L ^a   Gibran, Nicole S ^a   Antezana, Marcos A ^a   Carter, William G ^a,b   Olerud, John E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

db db; Diabetes mellitus; Diabetic; Keratinocyte; Laminin; Laminin 5; Laminin 332; Mouse; Wound healing

Indexed keywords

ALPHA6 INTEGRIN; BULLOUS PEMPHIGOID ANTIGEN 1; COLLAGEN TYPE 7; LAMININ 322; POLYURETHAN; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; WOUND CLOSURE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; BASEMENT MEMBRANE; CELL ADHESION MOLECULES; CELL MOVEMENT; COLLAGEN; DIABETES COMPLICATIONS; INTEGRINS; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, MUTANT STRAINS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 35649012060     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.07.002     Document Type: Article

References (47)

1. Pecoraro R.E., Reiber G.E., and Burgess E.M. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 13 5 (1990) 513-521
2. Reiber G.E. The epidemiology of diabetic foot problems. Diabet Med 13 Suppl 1 (1996) S6-S11
3. American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care 22 8 (1999) 1354-1360
4. Sullivan S., Underwood R., Gibran N., Sigle R.O., Usui M., Carter W.G., et al. Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg 113 3 (2004) 953-960
5. Tsuboi R., Shi C.M., Rifkin D.B., and Ogawa H. A wound healing model using healing-impaired diabetic mice. J Dermatol 19 11 (1992) 673-675
6. Ring B.D., Scully S., Davis C.R., Baker M.B., Cullen M.J., Pelleymounter M.A., et al. Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology 141 1 (2000) 446-449
7. Greenhalgh D.G., Sprugel K.H., Murray M.J., and Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136 6 (1990) 1235-1246
8. Debray-Sachs M., Dardenne M., Sai P., Savino W., Quiniou M.C., Boillot D., et al. Anti-islet immunity and thymic dysfunction in the mutant diabetic C57BL/KsJ db/db mouse. Diabetes 32 11 (1983) 1048-1054
9. Coleman D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14 3 (1978) 141-148
10. Mordes J.P., and Rossini A.A. Animal models of diabetes. Am J Med 70 2 (1981) 353-360
11. Olerud J.E., Usui M.L., Muffley L.A., Smith D.G., Larsen J.A., Gibran N.S., et al. Epithelial cells in the wound margins of diabetic ulcers are highly proliferative. J Invest Dermatol 114 4 (2000) 857
12. Andriessen M.P., van Bergen B.H., Spruijt K.I., Go I.H., Schalkwijk J., and van de Kerkhof P.C. Epidermal proliferation is not impaired in chronic venous ulcers. Acta Derm Venereol 75 6 (1995) 459-462
13. Stenn K.S., and dePalma L. Re-epithelialization. In: Clark R.A.F., and Henson P.M. (Eds). The molecular and cellular biology of wound repair (1988), Plenum Press, New York 321-335
14. Zhang K., and Kramer R.H. Laminin 5 deposition promotes keratinocyte motility. Exp Cell Res 227 2 (1996) 309-322
15. Carter W.G., Ryan M.C., and Gahr P.J. Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 65 4 (1991) 599-610
16. Vailly J., Verrando P., Champliaud M.F., Gerecke D., Wagman D.W., Baudoin C., et al. The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant. Eur J Biochem 219 1-2 (1994) 209-218
17. Rousselle P., Lunstrum G.P., Keene D.R., and Burgeson R.E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J. Cell Biol 114 3 (1991) 567-576
18. Nguyen B.P., Ren X.D., Schwartz M.A., and Carter W.G. Ligation of integrin alpha 3beta 1 by laminin 5 at the wound edge activates rho-dependent adhesion of leading keratinocytes on collagen. J Biol Chem 276 47 (2001) 43860-43870
19. Watt F.M. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21 15 (2002) 3919-3926
20. Goldfinger L.E., Hopkinson S.B., deHart G.W., Collawn S., Couchman J.R., and Jones J.C. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 112 Pt 16 (1999) 2615-2629
21. Hintermann E., Bilban M., Sharabi A., and Quaranta V. Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J Cell Biol 153 3 (2001) 465-478
22. Santoro M.M., Gaudino G., and Marchisio P.C. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Dev Cell 5 2 (2003) 257-271
23. Xia Y., Gil S.G., and Carter W.G. Anchorage mediated by integrin alpha6beta4 to laminin 5 (epiligrin) regulates tyrosine phosphorylation of a membrane-associated 80-kDa protein. J Cell Biol 132 4 (1996) 727-740
24. Gil S.G., Brown T.A., Ryan M.C., and Carter W.G. Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that ihibit hemidesmosome formation. J Invest Dermatol 103 Suppl 5 (1994) S31-S38
25. Ryan M.C., Lee K., Miyashita Y., and Carter W.G. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 145 6 (1999) 1309-1323
26. Frank D.E., and Carter W.G. Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci 117 Pt 8 (2004) 1351-1363
27. Shang M., Koshikawa N., Schenk S., and Quaranta V. The LG3 module of laminin-5 harbors a binding site for integrin alpha3beta1 that promotes cell adhesion, spreading, and migration. J Biol Chem 276 35 (2001) 33045-33053
28. O'Toole E.A., Marinkovich M.P., Hoeffler W.K., Furthmayr H., and Woodley D.T. Laminin-5 inhibits human keratinocyte migration. Exp Cell Res 233 2 (1997) 330-339
29. Yamada K.M., and Clark R.A. Provisional Matrix. In: Clark R.A. (Ed). The molecular and cellular biology of wound repair (1996), Plenum Press, New York 51-82
30. Burgeson R.E., Chiquet M., Deutzmann R., Ekblom P., Engel J., Kleinman H., et al. A new nomenclature for the laminins. Matrix Biol 14 3 (1994) 209-211
31. Goldfinger L.E., Stack M.S., and Jones J.C. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol 141 1 (1998) 255-265
32. Sigle R.O., Gil S.G., Bhattacharya M., Ryan M.C., Yang T.M., Brown T.A., et al. Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. J Cell Sci 117 Pt 19 (2004) 4481-4494
33. Carter W.G., Kaur P., Gil S.G., Gahr P.J., and Wayner E.A. Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J Cell Biol 111 6 Pt 2 (1990) 3141-3154
34. Nguyen B.P., Gil S.G., and Carter W.G. Deposition of laminin 5 by keratinocytes regulates integrin adhesion and signaling. J Biol Chem 275 41 (2000) 31896-31907
35. Matsui C., Wang C.K., Nelson C.F., Bauer E.A., and Hoeffler W.K. The assembly of laminin-5 subunits. J Biol Chem 270 40 (1995) 23496-23503
36. Marinkovich M.P., Lunstrum G.P., Keene D.R., and Burgeson R.E. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 119 3 (1992) 695-703
37. Fujita M., Usui M.L., Carter W.G., Ryan M.C., and Olerud J.E. Laminin 5 expression in acute and chronic wounds. J Invest Dermatol 112 4 (1999) 626
38. Coleman D.L. Diabetes-obesity syndromes in mice. Diabetes 31 Suppl 1, Pt 2 (1982) 1-6
39. Tanaka M., Hashimoto T., Dykes P.J., and Nishikawa T. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol 21 1 (1996) 23-27
40. Woodley D.T., Chang C., Saadat P., Ram R., Liu Z., and Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of Epidermolysis Bullosa Acquisita. J Invest Dermatol 124 (2005) 958-964
41. Boyce S.T., and Ham R.G. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 81 1 Suppl (1983) 33s-40s
42. Gil S.G., Sigle R.O., and Carter W.G. Detection and purification of instructive extracellular matrix components with monoclonal antibody technologies. Methods Cell Biol 69 (2002) 27-52
43. Martson M., Viljanto J., Laippala P., and Saukko P. Cranio-caudal differences in granulation tissue formation: an experimental study in the rat. Wound Repair Regen 7 2 (1999) 119-126
44. Crowe M.J., McNeill R.B., Schlemm D.J., Greenhalgh D.G., and Keller S.J. Topical application of yeast extract accelerates the wound healing of diabetic mice. J Burn Care Rehabil 20 2 (1999) 155-162
45. Spenny M.L., Muangman P., Sullivan S.R., Bunnett N.W., Ansel J.C., Olerud J.E., et al. Neutral endopeptidase inhibition in diabetic wound repair. Wound Repair Regen 10 5 (2002) 295-301
46. Antezana M., Sullivan S., Usui M., Gibran N., Spenny M., Larsen J., et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol 119 6 (2002) 1400-1404
47. Baker S.E., Hopkinson S.B., Fitchmun M., Andreason G.L., Frasier F., Plopper G., et al. Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly. J Cell Sci 109 Pt 10 (1996) 2509-2520